Growth Hormone & Igf Research

Papers
(The median citation count of Growth Hormone & Igf Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board25
Editorial Board21
Editorial Board19
Editorial Board15
Efficacy and safety of growth hormone therapy in children with Noonan syndrome15
Evaluation of growth hormone deficiency in women with unexplained infertility13
Low IGF-1 combined with a single clonidine stimulation test as a confirmatory tool for pediatric growth hormone deficiency12
Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular disease11
Prevalence of refractoriness when testing growth hormone levels in children10
IGF-1 knockdown inhibits phosphorylation of Akt and ERK in chicken embryonic myotubes9
Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature9
Response to growth hormone therapy in ring chromosome 15: Review and evidence from a new case on possible beneficial effect in neurodevelopment8
Assessment of body composition in active and controlled acromegaly by bioelectrical impedance analysis and dual-energy x-ray absorptiometry8
Growth hormone deficiency following traumatic brain injury in adults: Still much of a clinical enigma8
Biomarkers of growth and carbohydrate metabolism in neonatal rats supplemented with fish oil and/or antioxidants during intermittent hypoxia7
IGF-1 as a mediator in the association between body mass index and risk of liver cancer: A prospective analysis of 432,203 participants from the UK biobank7
Cognitive effects of growth hormone following traumatic brain injury and other disorders7
Editorial Board7
Impact of disease activity on cognitive and psychological outcomes in acromegaly: A prospective study6
Comparison of growth response and adverse reaction according to growth hormone dosing strategy for children with short stature: LG Growth Study6
Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study6
Editorial Board6
Editorial Board6
Efficacy, safety, and outcomes of growth hormone treatment in children with idiopathic short stature6
Editorial Board6
Body proportion is not affected by sex in LARON syndrome5
Growth hormone regulates deiodinase type 2 and 3 expression via GATA5
Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder5
The effect of methylphenidate on the dopamine and growth hormone response to exercise in children with attention-deficit hyperactivity disorder5
Pituitary hormone abnormalities following military-related traumatic brain injuries5
Editorial Board5
Evaluation of neuroendocrine deficits following traumatic brain injury: The role of a neurorehabilitation specialist5
Association of rs35767 polymorphism in the IGF1 gene with athletic performance in power and endurance sports: A meta-analysis5
Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly?4
Administration of insulin like growth factor I (IGF I) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease4
Editorial Board3
Duration-specific association between plasma IGFBP7 levels and diabetic complications in patients with type 2 diabetes mellitus3
Editorial Board3
Comparison of two prediction models in a clinical setting to predict growth in prepubertal children on recombinant growth hormone3
Administration study of somapacitan, a long-acting growth hormone derivative, in horse for doping control purpose3
Corrigendum to “Insulin-like growth Factors I and II receptors in the breast cancer disparity” among African-American women [Growth Hormone & IGF Research 20 (2010) 245–254]2
The coexistence of newly diagnosed acromegaly with primary empty sella: More frequent than expected?2
Altered gut microbiome and post traumatic hypopituitarism in chronic TBI: The need for recognition, evaluation and treatment2
Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study2
The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor2
Prostate-specific antigen (PSA) levels in men with Prader-Willi syndrome2
Adult patients with Laron syndrome tend to develop the metabolic syndrome2
Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences2
Prevalence and clinical correlates of pre-operative glucose homeostasis in patients with acromegaly2
Auxology – an update 20251
Editorial Board1
Is Somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from Somatropin to Somatrogon1
Pharmacodynamics, pharmacokinetics, and toxicology of Fc-growth hormone fusion protein in macaques1
Pediatric growth hormone deficiency: Understanding the patient and caregiver perspectives1
Effects of insulin-like growth factor-I and Progranulin on a human trophoblast model1
Editorial Board1
Identification and differentiation of somapacitan, a long-acting growth hormone derivative, and recombinant human growth hormone in equine plasma by LC-HRMS for doping control purpose1
Growth hormone responses during arginine and clonidine stimulation test: Correlations with patients' auxological and metabolic parameters in a single centre study1
In search of Vitruvian man1
A combined top-down and bottom-up LC-HRMS/MS method for the quantification of human growth hormone in plasma and serum1
The effect of treatment with somatostatin analogs in children with neurofibromatosis type 1 and growth hormone excess1
0.088335037231445